Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Anorexia 5Neoplasms 4Weight Loss 2Pancreatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Cachexia 2Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Neoplasm Metastasis 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1Depression 1Body Weight 1Anorexia Nervosa with Significantly Low Body Weight 1Advanced Cancer 1

Interventions

Exercise 10Diet 5Caloric Restriction 5Nutrition Assessment 4Metformin 4Octreotide 3Megestrol Acetate 3Cognitive Behavioral Therapy 3anamorelin 2Standard of Care 2Olanzapine 2Mirtazapine 2Melatonin 2Liraglutide 2Eicosapentaenoic Acid 2Diet, Carbohydrate-Restricted 2Diet Therapy 2sibutramine 1remune 1olanzapine-fluoxetine combination 1lime 1irinotecan sucrosofate 1bermekimab 1Weight Reduction Programs 1Tirzepatide 1TOPS 1Surveys and Questionnaires 1Sugars 1Sampling Studies 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Weight Loss × Mirtazapine × Clear all
NCT00488072 2026-01-26

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
98 enrolled

Anorexia, Sleep Initiation and Maintenance Disorders, Weight Loss

NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated
13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡